Kimia Biosciences (BOM:530313) Buyback Yield %: 0.00 (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530313 Kimia Biosciences Ltd BOM:530313
26 GF Score
Price ₹28.00
View Full Analysis

What is Kimia Biosciences Buyback Yield %?

Kimia Biosciences BOM:530313 -1.75% 26 Buyback Yield % is 0.00 as of Aug. 30, 2026. GuruFocus rates BOM:530313 with a GF Score™ of 26/100. Among 236 Drug Manufacturers companies, Kimia Biosciences ranks worse than 423728.39% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Kimia Biosciences's current buyback yield was 0.00%.

Kimia Biosciences Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Kimia Biosciences's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kimia Biosciences Buyback Yield % Chart

Kimia Biosciences Annual Data
Trend
Buyback Yield %

Kimia Biosciences Semi-Annual Data
Buyback Yield %

BOM:530313 vs ZTS: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kimia Biosciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kimia Biosciences Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kimia Biosciences's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Kimia Biosciences's Buyback Yield % falls into.


BOM:530313
26GF Score
Kimia Biosciences Ltd BOM:530313
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kimia Biosciences Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Kimia Biosciences's Buyback Yield for the fiscal year that ended in . 20 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- ( + ) /
=N/A%

Kimia Biosciences's annualized Buyback Yield for the quarter that ended in . 20 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- ( + ) /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Kimia Biosciences (BOM:530313) has a Buyback Yield % of 0.00 as of Aug. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Kimia Biosciences and its competitors. According to the industry distribution chart, Kimia Biosciences ranks #999999 out of 236 companies in the Drug Manufacturers industry.
Is Kimia Biosciences' Buyback Yield % too high?
Kimia Biosciences' current Buyback Yield % is 0.00. Based on the distribution chart, Kimia Biosciences ranks #999999 out of 236 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Kimia Biosciences has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Kimia Biosciences' Buyback Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kimia Biosciences ranks #999999 out of 236 companies for Buyback Yield %. This places Kimia Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Kimia Biosciences and its competitors. Kimia Biosciences's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kimia Biosciences stock overvalued right now?
Kimia Biosciences (BOM:530313) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Kimia Biosciences' overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Kimia Biosciences (BOM:530313), the current Buyback Yield % is 0.00 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kimia Biosciences Business Description

Address Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Prucalopride, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.
26GF Score

Get the complete analysis for BOM:530313

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹28.00
Price